Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cannabidiol 100mg/ml oral solution sugar free
0408010AMAAAAAA
|
Cannabidiol | Cannabidiol | Central Nervous System | 11 |
|
Epidyolex 100mg/ml oral solution
0408010AMBCAAAA
|
Epidyolex | Cannabidiol | Central Nervous System | 5 |
|
Cannabidiol 25mg/ml oral solution sugar free
0408010AMAAABAB
|
Cannabidiol | Cannabidiol | Central Nervous System | No data available |
|
Epidiolex 100mg/ml oral solution
0408010AMBBAAAA
|
Epidiolex | Cannabidiol | Central Nervous System | No data available |
|
Epidiolex 25mg/ml oral solution
0408010AMBBABAB
|
Epidiolex | Cannabidiol | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.